Ritratto di claudia.stefanutti@uniroma1.it

Benvenuti! 

 

Sede: Policlinico Umberto I, Edificio I Clinica Medica, III Piano Montacarichi - Citofono

 

Attività assistenziale primaria: Tecniche Terapeutiche Extracorporee

Insegnamento Codice Anno Corso - Frequentare
MEDICINA INTERNA E CHIRURGIA GENERALE III 10596615 2021/2022 Medicina e chirurgia 'C' (abilitante all'esercizio della professione di Medico Chirurgo) - Roma Azienda Policlinico Umberto I
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2021/2022 Medicina e chirurgia "C" - Roma Azienda Policlinico Umberto I
MEDICINA INTERNA E CHIRURGIA GENERALE III 10596615 2020/2021 Medicina e chirurgia "C" - Roma Azienda Policlinico Umberto I
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2020/2021 Medicina e chirurgia "C" - Roma Azienda Policlinico Umberto I
METODOLOGIA MEDICO SCIENTIFICA PRE-CLINICA 1056190 2019/2020 Medicina e chirurgia "E" Polo Pontino
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2019/2020 Medicina e chirurgia "C" - Roma Azienda Policlinico Umberto I
ANATOMIA UMANA 1026645 2019/2020 Medicina e chirurgia "E" Polo Pontino
ANATOMIA UMANA 1026645 2018/2019 Medicina e chirurgia 'E'
METODOLOGIA MEDICO SCIENTIFICA PRE-CLINICA 1056190 2018/2019 Medicina e chirurgia 'E'
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2018/2019 Medicina e chirurgia 'C'
DIAGNOSTICA VASCOLARE 1052073 2017/2018 Tecniche di radiologia medica, per immagini e radioterapia (abilitante alla professione sanitaria di Tecnico di radiologia medica) ROMA - Corso di laurea A - Roma Azienda Policlinico Umberto I
METODOLOGIA MEDICO SCIENTIFICA DI BASE 1026636 2017/2018 Medicina e chirurgia 'E'
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2017/2018 Medicina e chirurgia 'C'
ANATOMIA UMANA 1026645 2017/2018 Medicina e chirurgia 'E'
MEDICINA INTERNA E CHIRURGIA GENERALE III 1026309 2016/2017 Medicina e chirurgia 'C'
ANATOMIA UMANA 1026645 2016/2017 Medicina e chirurgia 'E'
Titolo Rivista Anno
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a) JOURNAL OF CLINICAL LIPIDOLOGY 2020
Evolocumab in pediatric heterozygous familial hypercholesterolemia NEW ENGLAND JOURNAL OF MEDICINE 2020
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action JAMA CARDIOLOGY 2020
Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia CURRENT ATHEROSCLEROSIS REPORTS 2020
Lipid profile and left ventricular geometry pattern in obese children LIPIDS IN HEALTH AND DISEASE 2020
Evolocumab in pediatric heterozygous familial hypercholesterolemia NEW ENGLAND JOURNAL OF MEDICINE 2020
A successful term pregnancy with severe hypertriglyceridaemia and acute pancreatitis. Clinical management and review of the literature ATHEROSCLEROSIS SUPPLEMENTS 2019
A complicated pregnancy in homozygous familial hypercholesterolaemia treated with lipoprotein apheresis: A case report ATHEROSCLEROSIS SUPPLEMENTS 2019
Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis ATHEROSCLEROSIS SUPPLEMENTS 2019
Familial hypercholesterolaemia: the influence of lipoprotein apheresis on choroid and retina. an oct and octa retrospective study INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 2019
A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study JOURNAL OF CLINICAL LIPIDOLOGY 2019
Looking at Lp(a) and Related Cardiovascular Risk: from Scientific Evidence and Clinical Practice CURRENT ATHEROSCLEROSIS REPORTS 2019
Serum uric acid and left ventricular geometry pattern in obese children ATHEROSCLEROSIS SUPPLEMENTS 2019
Homozygous familial hypercholesterolaemia in childhood – The first case report in Southeast Europe ATHEROSCLEROSIS SUPPLEMENTS 2019
Efficacy and safety of PCSK9 monoclonal antibodies EXPERT OPINION ON DRUG SAFETY 2019
Identification and diagnosis of patients with familial chylomicronemia syndrome (FCS): Expert Panel recommendations and proposal of an FCS Score ATHEROSCLEROSIS 2018
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score DATA IN BRIEF 2018
Hypercholesterolaemia - practical information for non-specialists ARCHIVES OF MEDICAL SCIENCE 2018
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia JOURNAL OF CLINICAL LIPIDOLOGY 2018
Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report JOURNAL OF CLINICAL APHERESIS 2018
Dipartimento
MEDICINA MOLECOLARE
SSD

MED/50